Testing effectiveness (Phase 2)Looking for participantsNCT05664893
What this trial is testing
Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)
Who this might be right for
HER2 Negative Breast Cancer Not Immediately Operated
Centre Antoine Lacassagne 85